Amenorrhoea, menopause, and endocrine therapy for breast cancer.
Amir
Eitan
E
Department of Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada M5G 2M9.
Seruga
Bostjan
B
Freedman
Orit
O
Clemons
Mark
M
D000568:Amenorrhea / Q000209:etiology*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003951:Diagnostic Errors; D005260:Female; D019584:Hot Flashes / Q000139:chemically induced; D006801:Humans; D008487:Medical History Taking; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen